Episodic breathlessness in patients with advanced disease: A systematic review

Journal of Pain and Symptom Management

Volumn 45, Issue 3, 2013, Pages 561-578

  Simon, Steffen T ^a,b   Bausewein, Claudia ^a,f   Schildmann, Eva ^c   Higginson, Irene J ^f   Magnussen, Helgo ^e   Scheve, Christine ^a,d   Ramsenthaler, Christina ^a,f  

^a Institute of Palliative Care   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c HELIOS KLINIKUM BERLIN BUCH   (Germany)

^d Evangelical Hospital   (Germany)

^e KRANKENHAUS GROSSHANSDORF   (Germany)

^f KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Advanced disease; chronic heart failure; chronic obstructive pulmonary disease; dyspnea; episodic; lung cancer

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COPING BEHAVIOR; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DYSPNEA; EMOTION; EPISODIC BREATHLESSNESS; EXERCISE; HUMAN; LUNG CANCER; MEDICAL TERMINOLOGY; NEOPLASM; PERSONAL EXPERIENCE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW;

CRITICAL ILLNESS; DYSPNEA; HUMANS; PALLIATIVE CARE; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TERMINAL CARE;

EID: 84875230715     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2012.02.022     Document Type: Review

References (47)

1. S. Booth, S. Silvester, and C. Todd Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers Palliat Support Care 1 2003 337 344
2. American Thoracic Society Dyspnea. Mechanisms, assessment, and management: a consensus statement Am J Respir Crit Care Med 159 1999 321 340
3. S.K. Reddy, H.A. Parsons, A. Elsayem, J.L. Palmer, and E. Bruera Characteristics and correlates of dyspnea in patients with advanced cancer J Palliat Med 12 2009 29 36
4. Y.L. Lai, C.W.H. Chan, and V. Lopez Perceptions of dyspnea and helpful interventions during the advanced stage of lung cancer: Chinese patients' perspectives Cancer Nurs 30 2007 E1 E8
5. I. Henoch, B. Bergman, and E. Danielson Dyspnea experience and management strategies in patients with lung cancer Psychooncology 17 2008 709 715
6. I. Henoch, B. Bergman, M. Gustafsson, F. Gaston Johansson, and E. Danielson Dyspnea experience in patients with lung cancer in palliative care Eur J Oncol Nurs 12 2008 86 96
7. M. O'Driscoll, J. Corner, and C. Bailey The experience of breathlessness in lung cancer Eur J Cancer Care 8 1999 37 43
8. M.M.V. Heinzer, C. Bish, and R. Detwiler Acute dyspnea as perceived by patients with chronic obstructive pulmonary disease Clin Nurs Res 12 2003 85 101
9. A.H. Navigante, M.A. Castro, and L.C. Cerchietti Morphine versus midazolam as upfront therapy to control dyspnea perception in cancer patients while its underlying cause is sought or treated J Pain Symptom Manage 39 2010 820 830
10. A.H. Navigante, L.C. Cerchietti, M.A. Castro, M.A. Lutteral, and M.E. Cabalar Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer J Pain Symptom Manage 31 2006 38 47
11. P.H. Bailey The dyspnea-anxiety-dyspnea cycle-COPD patients' stories of breathlessness: "It's scary/when you can't breathe" Qual Health Res 14 2004 760 778
12. A.P. Abernethy, D.C. Currow, and P. Frith Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea BMJ 327 2003 523 528
13. Y. Lacasse, R. Goldstein, T.J. Lasserson, and S. Martin Pulmonary rehabilitation for chronic obstructive pulmonary disease Cochrane Database Syst Rev 4 2006 CD003793
14. S. Booth, S.H. Moosavi, and I.J. Higginson The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy Nat Clin Pract Oncol 5 2008 90 100
15. A.N. Davies, A. Dickman, C. Reid, A.M. Stevens, and G. Zeppetella The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland Eur J Pain 13 2009 331 338
16. A. Liberati, D.G. Altman, and J. Tetzlaff The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration Ann Intern Med 151 2009 W65 W94
17. Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) Global strategy for diagnosis, management, and prevention of COPD Available from http://www.goldcopd.org 2010 Accessed October 4, 2011
18. Heart Failure Society of America NYHA classification Available from http://www.abouthf.org/questions-stages.htm 2002 Accessed October 4, 2011
19. National Institute for Health and Clinical Excellence The guidelines manual 2009 National Institute for Health and Clinical Excellence London
20. A. Edwards, K. Hood, and E. Matthews The effectiveness of one-to-one risk communication interventions in health care: a systematic review Med Decis Making 20 2000 290 297
21. S. Hawker, S. Payne, C. Kerr, M. Hardey, and J. Powell Appraising the evidence: reviewing disparate data systematically Qual Health Res 12 2002 1284 1299
22. T. Aamodt, R. Dahle, and O. Horgen Effects of withdrawal of sustained-release theophylline in patients with chronic obstructive lung disease Allergy 43 1988 411 414
23. C. Michaels, P.M. Meek, and S. Dedkhard Breathing intensity and word use in individuals with COPD Chron Respir Dis 5 2008 197 204
24. S. Janson Bjerklie, V.K. Carrieri, and M. Hudes The sensations of pulmonary dyspnea Nurs Res 35 1986 154 159
25. M. Barnett Chronic obstructive pulmonary disease: a phenomenological study of patients' experiences J Clin Nurs 14 2005 805 812
26. M.A. Benitez-Rosario, A.S. Martin, and M. Feria Oral transmucosal fentanyl citrate in the management of dyspnea crises in cancer patients J Pain Symptom Manage 30 2005 395 397
27. A.A. Gauna, S.K. Kang, M.L. Triano, E.R. Swatko, and V.J. Vanston Oral transmucosal fentanyl citrate for dyspnea in terminally ill patients: an observational case series J Palliat Med 11 2008 643 648
28. T. Sitte, and C. Bausewein Intranasal fentanyl for episodic breathlessness J Pain Symptom Manage 36 2008 e3 e6
29. M.A. Charles, L. Reymond, and F. Israel Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline J Pain Symptom Manage 36 2008 29 38
30. M. Gysels, and I.J. Higginson Access to services for patients with chronic obstructive pulmonary disease: the invisibility of breathlessness J Pain Symptom Manage 36 2008 451 460
31. A.J. DeVito Dyspnea during hospitalizations for acute phase of illness as recalled by patients with chronic obstructive pulmonary disease Heart Lung 19 1990 186 191
32. D.D. Fraser, C.C. Kee, and P. Minick Living with chronic obstructive pulmonary disease: insiders' perspectives J Adv Nurs 55 2006 550 558
33. J. Gullick, and M.C. Stainton Living with chronic obstructive pulmonary disease: developing conscious body management in a shrinking life-world J Adv Nurs 64 2008 605 614
34. K. Ek, and B.M. Ternestedt Living with chronic obstructive pulmonary disease at the end of life: a phenomenological study J Adv Nurs 62 2008 470 478
35. K. Lomborg, A. Bjorn, R. Dahl, and M. Kirkevold Body care experienced by people hospitalized with severe respiratory disease J Adv Nurs 50 2005 262 271
36. A. Fraticelli, R. Gesuita, A. Vespa, and E. Paciaroni Congestive heart failure in the elderly requiring hospital admission Arch Gerontol Geriatr 23 1996 225 238
37. L.A. Thomas Effective dyspnea management strategies identified by elders with end-stage chronic obstructive pulmonary disease Appl Nurs Res 22 2009 79 85
38. R.A. Mularski, L.F. Reinke, V. Carrieri-Kohlmann, and M.D. Fischer Dyspnea crisis: a consensus definition for a novel clinical entity Chest 138 2010 233A
39. S. Mercadante, L. Radbruch, and A. Caraceni Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care Cancer 94 2002 832 839
40. R.K. Portenoy, and N.A. Hagen Breakthrough pain: definition, prevalence and characteristics Pain 41 1990 273 281
41. A. Davies, G. Zeppetella, and S. Andersen Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies Eur J Pain 15 2011 756 763
42. K.S. Christensen, A.E. Cohen, and F.H. Mermelstein The analgesic efficacy and safety of a novel intranasal morphine formulation (morphine plus chitosan), immediate release oral morphine, intravenous morphine, and placebo in a postsurgical dental pain model Anesth Analg 107 2008 2018 2024
43. P.J. Coyne The use of nebulized fentanyl for the management of dyspnea Clin J Oncol Nurs 7 2003 334 335
44. M. Farquhar, I.J. Higginson, P. Fagan, and S. Booth Results of a pilot investigation into a complex intervention for breathlessness in advanced chronic obstructive pulmonary disease (COPD): brief report Palliat Support Care 8 2010 143 149
45. M.C. Farquhar, A.T. Prevost, and P. McCrone Study protocol: phase III single-blinded fast-track pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease Trials 12 2011 130
46. M. Gysels, C. Bausewein, and I.J. Higginson Experiences of breathlessness: a systematic review of the qualitative literature Palliat Support Care 5 2007 281 302
47. C.P. Escalante, C.G. Martin, and L.S. Elting Dyspnea in cancer patients: etiology, resource utilization, and survival-implications in a managed care world Cancer 78 1996 1314 1319